View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Doxorubicin 25 / Vinblastine 6 / Dacarbazine 375 / Brentuximab Vedotin 1,2, Hodgkin Lymphoma
Protocol-ID: 587 V1.0 (Mini), AVD (DOXO25/VNBL6/DCRB375)/BRNT1.2, HodgkinIndication(s)
- Hodgkin Lymphoma; ICD-10 C81.-
Links
- Stephen M. Ansell, First-line brentuximab vedotin plus chemotherapy to improve overall survival in patients with stage III/IV classical Hodgkin lymphoma: An updated analysis of ECHELON-1. ASCO 2022; J Clin Oncol 40, 2022 (suppl 16; abstr 7503) [DOI]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 21.05.2018